Skip to content
Screener

Rani Therapeutics Holdings, Inc. RANI Q2 2026 earnings

Reported August 13, 2026 · After market close

Revenue$1.7MBeat by $784.0K
EPS-$0.04Beat by $0.01
Revenue estimate$925.0K
EPS estimate-$0.05

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$1.3M
EPS estimate-$0.05

FAQ

When did Rani Therapeutics Holdings, Inc. report Q2 2026 earnings?
Rani Therapeutics Holdings, Inc. (RANI) reported Q2 2026 earnings on August 13, 2026 after market close.
What were Rani Therapeutics Holdings, Inc.'s Q2 2026 revenue and EPS?
Rani Therapeutics Holdings, Inc. reported revenue of $1.7M and eps of $-0.04 for Q2 2026.
Did Rani Therapeutics Holdings, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $925.0K by $784.0K. EPS beat the consensus estimate of $-0.05 by $0.01.
How did Rani Therapeutics Holdings, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 77.8% from $-0.18.
Where can I find Rani Therapeutics Holdings, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-349197) and the 10-Q periodic report (0001193125-26-349245) directly on SEC EDGAR. The filing index links above go to sec.gov.